World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
48
Citations
10387
World Ranking
4646
National Ranking
107

Overview

Marie Paule Kieny is affiliated with the Drugs for Neglected Diseases Initiative in Switzerland. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with significant contributions to Infectious Diseases, Economics and Econometrics, Public Health, Environmental and Occupational Health, Molecular Biology, and Immunology.

The scientist's work focuses on a range of topics including SARS-CoV-2 and COVID-19 research, COVID-19 clinical research studies, health systems, economic evaluations, quality of life, COVID-19 epidemiological studies, science, research, and medicine, health and medical research impacts, as well as pharmaceutical economics and policy.

Recent papers authored or co-authored by the scientist include:

  • SARS-CoV-2 variants and ending the COVID-19 pandemic, 2021, The Lancet
  • Reboot biomedical R&D in the global public interest, 2022, Nature
  • Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story, 2023, BMJ Global Health
  • A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project, 2022, Nature Medicine
  • Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination), 2021, Vaccine

The scientist frequently collaborates with others in their field. Notable frequent co-authors include John-Arne Røttingen, Corinne Desaint, M. Lefèbvre, Anne Radenne, and Béatrice Parfait.

Prominent venues where their work has been published include The Lancet, Nature, BMJ Global Health, iScience, and Nature Medicine.

Best Publications

  • Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.

    Evelina Tacconelli;Elena Carrara;Alessia Savoldi;Stephan Harbarth

  • Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

    Hongchao Pan;Richard Peto;Ana-Maria Henao-Restrepo

  • Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

    Ana Maria Henao-Restrepo;Anton Camacho;Ira M. Longini;Conall H. Watson

  • Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

    Ana Maria Henao-Restrepo;Ira M Longini;Matthias Egger;Matthias Egger;Natalie E Dean

  • HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product

    Bruno Guy;Marie Paule Kieny;Yves Riviere;Christian Le Peuch

  • Expression of rabies virus glycoprotein from a recombinant vaccinia virus

    M. P. Kieny;R. Lathe;R. Drillien;D. Spehner

  • The 2009 A (H1N1) influenza virus pandemic: A review.

    Marc P. Girard;John S. Tam;Olga M. Assossou;Marie Paule Kieny

  • SARS-CoV-2 variants and ending the COVID-19 pandemic.

    Arnaud Fontanet;Arnaud Fontanet;Brigitte Autran;Bruno Lina;Marie Paule Kieny

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

    T J Wiktor;R I Macfarlan;K J Reagan;B Dietzschold

  • Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine

    Bernard Brochier;M. P. Kieny;F. Costy;P. Coppens

  • Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

    J. Blancou;M. P. Kieny;R. Lathe;J. P. Lecocq

  • The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

    Angela Huttner;Julie-Anne Dayer;Sabine Yerly;Christophe Combescure

  • Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.

    Anne G. Laurent-Crawford;Bernard Krust;Yves Riviére;Claude Desgranges

  • A review of vaccine research and development: meningococcal disease.

    Marc P. Girard;Marie-Pierre Preziosi;Maria-Teresa Aguado;Marie Paule Kieny

  • The International Ebola Emergency

    Sylvie Briand;Eric Bertherat;Paul Cox;Pierre Formenty

  • Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

    Milagritos D. Tapia;Samba O. Sow;Kirsten E. Lyke;Fadima Cheick Haidara

  • A review of vaccine research and development: human acute respiratory infections.

    Marc P. Girard;Thomas Cherian;Yuri Pervikov;Marie Paule Kieny

  • A review of vaccine research and development: human enteric infections.

    Marc P. Girard;Duncan Steele;Claire-Lise Chaignat;Marie Paule Kieny

  • A review of vaccine research and development : The human immunodeficiency virus (HIV)

    Marc P. Girard;Saladin K. Osmanov;Marie Paule Kieny

  • Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

    Guerrino Meneguzzi;Christa Cerni;Marie Paule Kieny;Richard Lathe;Richard Lathe

  • Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins.

    Y Riviere;F Tanneau-Salvadori;A Regnault;O Lopez

  • A review of human vaccine research and development: malaria.

    Marc P. Girard;Zarifah H. Reed;Martin Friede;Marie Paule Kieny

  • Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic

    Ellen Murphy;Bette Korber;Marie-Claude Georges-Courbot;Bruno You

  • Vaccine Protection of Chimpanzees Against Challenge with HIV-1-Infected Peripheral Blood Mononuclear Cells

    Patricia N. Fultz;Peter Nara;Francoise Barre-Sinoussi;Agnes Chaput

  • Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

    Olga De Santis;Régine Audran;Emilie Pothin;Loane Warpelin-Decrausaz

  • A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)

    Gilles Pialoux;Jean-Louis Excler;Yves Rivière;Gustavo Gonzalez-Canali

  • Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer.

    Susy M. Scholl;Jean-Marc Balloul;Gwenaelle Le Goc;Nadine Bizouarne

  • Mutational analysis of the HIV nef protein

    B. Guy;Y. Rivière;K. Dott;A. Regnault

  • Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.

    Thomas Müller;Bernhard Dietzschold;Hildegund Ertl;Anthony R. Fooks

  • Vaccination against tumor cells expressing breast cancer epithelial tumor antigen.

    Mara Hareuveni;Claudie Gautier;Marie-Paule Kieny;Daniel Wreschner

  • Tumour prevention and rejection with recombinant vaccinia.

    R. Lathe;M. P. Kieny;P. Gerlinger;P. Clertant

Frequent Co-Authors

Richard Lathe
Richard Lathe University of Edinburgh
Pierre Chambon
Pierre Chambon Institute of Genetics and Molecular and Cellular Biology
Luc Montagnier
Luc Montagnier Institut Pasteur
Paul-Pierre Pastoret
Paul-Pierre Pastoret University of Liège
André Kirn
André Kirn Grenoble Alpes University
Catherine Tomasetto
Catherine Tomasetto Institute of Genetics and Molecular and Cellular Biology
Marc Girard
Marc Girard Institut Pasteur
Ara G. Hovanessian
Ara G. Hovanessian Centre national de la recherche scientifique, CNRS
Guerrino Meneguzzi
Guerrino Meneguzzi Université Côte d'Azur
Stéphane Paul
Stéphane Paul Centre Hospitalier Universitaire de Saint-Étienne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a wide range of career opportunities, many of which can be enhanced through specialized online degrees and certifications. For example, professionals interested in healthcare may explore pathways towards becoming a Functional Medicine Nurse Practitioner. Understanding the functional medicine np salary and role can guide students seeking an advanced nursing career that integrates microbiology concepts with patient care.

In addition to clinical roles, the growing importance of medical coding in healthcare administration offers a robust career track. Earning a certified professional coder certification can lead to jobs that support healthcare providers by ensuring accurate coding and billing, a vital link between microbiological research data and practical healthcare applications.

Another promising field is Health Information Management, where professionals manage patient data and healthcare technologies. Learning about health information management jobs salary and growth prospects can help students align their microbiology background with healthcare information systems.

For those pursuing this area, enrolling in one of the best online health information management degree cahiim accredited programs ensures quality education and accreditation, crucial for career advancement. Combining microbiological expertise with health information skills leads to diverse and in-demand careers in the healthcare industry.

Best Scientists Citing Marie Paule Kieny

Trending Scientists